Optiscan Imaging LimitedASX: OIL

Appendix 4E - Preliminary Final Report

· Issued by Optiscan Imaging Limited

Filed with ASX · · 3 pages · English

Summary by 6ix AI

The report indicates a decrease in revenues from ordinary activities compared to the previous year, alongside an increase in losses attributable to the owners of the company. The company also reported a significant rise in research and development incentive income, reflecting successful initiatives in overseas R&D. Despite the losses, Optiscan Imaging Limited has advanced multiple R&D projects and introduced new medical imaging devices during the financial year.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Optiscan Imaging Limited on 6ix

Earlier from Optiscan Imaging

Later from Optiscan Imaging

All Optiscan Imaging news releases